Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis
Authors:
- Ji Seon KimJKJi Seon Kim
- Sook-Hyang JeongSJSook-Hyang Jeong
- Yu Kyeong KimYKYu Kyeong Kim
- Sang Eun KimSKSang Eun Kim
- Suk Hwan KimSKSuk Hwan Kim
- Yangho KimYKYangho Kim
- 1 August 2010
- journal article
- case report
- Published by Elsevier in NeuroToxicology
- Vol. 31 (4) , 351-355
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2009K001257, BAERI 20090078370, KRF-2006-311-E00271)
- Ministry of Education, Science and Technology
- Seoul National University Bundang Hospital (02-2005-027)
This publication has 23 references indexed in Scilit:
- Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonismJournal of Neurochemistry, 2008
- Neuroimaging in manganismNeuroToxicology, 2006
- Acute manganese administration alters dopamine transporter levels in the non-human primate striatumNeuroToxicology, 2006
- [18F]FDOPA PET and clinical features in parkinsonism due to manganismMovement Disorders, 2005
- High Signal Intensities on T1-Weighted MRI as a Biomarker of Exposure to Manganese.Industrial Health, 2004
- Whole Blood Manganese Correlates with High Signal Intensities on T1-Weighted MRI in Patients with Liver CirrhosisNeuroToxicology, 2003
- Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean?Movement Disorders, 2002
- Chronic acquired hepatocerebral degeneration: Case reports and new insightsMovement Disorders, 1995
- Altered Cerebral Blood Flow and Glucose Metabolism in Patients with Liver Disease and Minimal EncephalopathyJournal of Cerebral Blood Flow & Metabolism, 1991
- THE ACQUIRED (NON-WILSONIAN) TYPE OF CHRONIC HEPATOCEREBRAL DEGENERATIONMedicine, 1965